Ethyl 4-(2-amino-6-chloropyrimidin-4-yl)piperazine-1-carboxylate

Catalog No.: 
ACCHVP396
CAS No.: 
860650-69-7
Molecular Formula: 
C11H16ClN5O2
Molecular Weight: 
285.73
Ethyl 4-(2-amino-6-chloropyrimidin-4-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$110.00InquiryInquiry
1g90%$324.00InquiryInquiry
5g90%$1588.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 4-(2-amino-6-chloropyrimidin-4-yl)piperazine-1-carboxylate
IUPAC Nameethyl 4-(2-amino-6-chloropyrimidin-4-yl)piperazine-1-carboxylate
Molecular FormulaC11H16ClN5O2
Molecular Weight285.73
SMILESO=C(N1CCN(C2=NC(N)=NC(Cl)=C2)CC1)OCC
InChI KeyMPSNLJWSIKJEGX-UHFFFAOYSA-N
Synonymethyl 4-(2-amino-6-chloropyrimidin-4-yl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-(2-amino-6-chloro-4-pyrimidinyl)-, ethyl ester
CAS No.860650-69-7

Synthetic Route by SureRoute

1. ACCHVP396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPYCL530 route compound structure diagram
    ACPYCL530120-43-4In Stock
  2. Plus
  3. ACMUJE870 route compound structure diagram
    ACMUJE8701194-21-4In Stock
  4. Then
  5. ACCHVP396 route product structure diagram
    ACCHVP396860650-69-7
Inquiry

2. ACCHVP396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPYCL530 route compound structure diagram
    ACPYCL530120-43-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCHVP396 route product structure diagram
    ACCHVP396860650-69-7
Inquiry

3. ACCHVP396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCHVP396 route product structure diagram
    ACCHVP396860650-69-7
Inquiry

Comments (0)